Archive
Proactive news snapshot: Jersey Oil & Gas, Flying Brands, Itaconix …
A glance at some of the day's highlights from the Proactive Investors newswire
Company
Allergy Therapeutics PLC
LON:AGY
Allergy Therapeutics PLC is an international commercial biotechnology company, headquartered in the UK, focussed on the treatment and diagnosis of allergic disorders, including aluminium free immunotherapy vaccines that have the potential to cure disease. The company sells proprietary and third-party products from its subsidiaries in nine major European countries and via distribution agreements in an additional ten countries.
298 stories · page 3 of 3
Allergy Therapeutics set to begin phase II trial of PQ Grass hay fever treatment “imminently”
The allergy vaccine specialist has received regulatory approval to start the phase II trial
Archive
Proactive news snapshot: ANGLE, Jersey Oil & Gas, Mosman Oil And Gas …
A glance at some of the day's highlights from the Proactive Investors newswire
Zibao Metals shines as it confirms revenue and profit growth this year
Some of the main news-driven risers and fallers at 3.35pm...
Allergy Therapeutics strengthens clinical research team with senior appointments
Pieter-Jan de Kam joins as clinical director, while Simon Piggott will become head of clinical science
FTSE 100 closes almost 36pts up as traders buy back in
The blue chip index closed out almost 36 points higher at 7,413
Archive
Proactive news snapshot: Kin Group, Allergy Therapeutics, 88 Energy ...
A glance at some of the stories on the Proactive newswire today
Investments and investor services
IG Group: up the polls!
Companies featured: HaloSource, Ascent Resources, Inspirit Energy, Clear Leisure, Safestyle, Nyota MInerals, IG Group, Polemos, Ortac Resources
Allergy Therapeutics sales soar as market share in Europe rises
Allergy continued to gain market share in Europe with its hay fever vaccines Pollinex Quattro and Pollinex
Allergy Therapeutics revenues rise as hay fever portfolio cleans up
Finncap's revenue forecasts were upgraded by 6% and 7% to £72.2mln and £79.5mln for the full year 2017 and 2018 respectively.
Archive
Proactive news round-up: Gfinity, MySQUAR, Sound Energy…
A glance at some of the stories on the Proactive newswire today
Microgen surges on back of "exceptional level of demand" for its Aptitude software
Microgen reckons full-year performance will be significantly ahead of expectations
Allergy Therapeutics publishes pre-clinical data on malaria and flu vaccines
The studies were carried out through Allergy’s Bencard Adjuvant Systems division.
FTSE 100 pares losses despite sharp fall in US equities
Lancashire Holdings rose in sympathy with Novae as the Lloyd's specialist insurer sold out to AXIS Holdings
Archive
Proactive News round-up: Obtala, Sabien Technology, Sound Energy ...
A glance at some of the stories on the Proactive newswire today
Long wait to supply Airbus is over for Hardide
Some of the largest risers and fallers in London at 3.15pm
Allergy Therapeutics confident of further growth
Its European markets were largely flat but the company still managed to achieve top-line growth of 18% on a constant currency basis
Archive
Have a break, have a Brexit
Article 50 will be triggered on Wednesday but there is still a lot of horse trading to be done over the coming months before Britain's departure from the EU is settled
Market likes Amerisur 's Colombia acquisition
Some of the main risers and fallers at 3.45pm: Amerisur Resources, PCG Entertainment
Allergy Therapeutics recruits first patients to its phase III birch trial
The year-long study over 50 sites in Germany, Sweden, Austria and Poland
Investments and investor services
FTSE 100, 250 and smallcaps all mark record highs after Fed rate hike and cap
FTSE 100 stocks ended solidly higher on Thursday after chalking a fresh record high as investors reacted to a tempered rate hike outlook in the US and relief at the defeat of the anti-immigration Freedom party in the Dutch election
Archive
Proactive news round-up: Allergy Therapeutics, Sunrise Resources, KEFI Minerals ...
A glance at some of the stories on the Proactive newswire today.
Allergy Therapeutics launches phase I trial of dust mite inoculation
A total of 32 patients will receive Acarovac MPL. The trial is expected to take 12 months from start to finish.
FTSE 100 shares slid despite high-flying Tui
The FTSE 100 just didn’t travel on Tuesday as the blue-chip ticker gave up light gains to end lower despite bumper results from travel firm Tui
Archive
Proactive news summary: Keywords confirms sparkling 2016
Also featured: Allergy Therapeutics, DP Poland, Eckoh, Harvest Minerals, Metal Tiger, Scotgold Resources, Sound Energy
Allergy Therapeutics unveils new non-executive director
Jean-Yves Pavee retired from the board last night and has been replaced by Jeff Barton, who has been nominated by Abbott Laboratories.
Allergy Therapeutics peanut allergy vaccine to move into phase I trials after pre-clinical success
The company is developing Polyvac as a short course of injections that is safer and more effective than the current treatments.
Archive
Proactive news highlights: Featuring Sound Energy; Shanta Gold, Allergy Therapeutics and more…
Sound Energy’s latest Morocco well flowed close to a billion cubic feet of gas during tests; Shanta Gold said it’s ahead of both cost and production targets; plus much more…
Not to be sneezed at - Allergy Therapeutics revenues up 18%
The company, which has developed short course inoculations against hay fever, said turnover was £40.4mln in the six months ended December 31.
Archive
Proactive news round-up: Satellite Solutions Worldwide, C4X Discovery, Tissue Regenix …
A glance at some of the stories on the Proactive newswire today
Broker 'nuts' about Allergy Therapeutics; reckons stock could double in value
Initiating coverage of the vaccines business, finnCap set a price target of 40p a share based on its analysis of the company’s peer group.
Proactive news highlights: BATM, Victoria Oil & Gas, Allergy Therapeutics
BATM secures a contract down under; Victoria Oil & Gas starts development drilling in Cameroon; Allergy Therapeutics secures European patent; plus much more
Risers and fallers: Next, Sirius Minerals, Victoria Oil & Gas
Shares in Victoria Oil & Gas were up after it spudded two development wells at its Logbaba gas field in Cameroon
Proactive news round-up: Eurasia Mining, Scancell, Metal Tiger ...
A glance at today's Proactive small -cap stories from the newswire
Allergy Therapeutics' malaria boost
The firm's scientists used what’s called an adjuvant, which enhances the body’s immune response to an illness or disease.
Riser and fallers: UK Mail Group, Allergy Therapeutics, Easyhotel...
German courier giant Deutsche Post DHL Group has agreed to acquire UK Mail for more than £240mln
FTSE 100 shares end higher, led by commodity-related stocks
FTSE 100 stocks ended higher on Wednesday after a see-saw session, after recovering from a bout of downside this week on the fate of Germany’s biggest lender Deutsche Bank when commodity-related shares advanced
Risers and fallers: Lamprell, Sports Direct, Summit Therapeutics...
Lamprell shares soared after it secured a US$90mln contract to transform a shipping vessel into floating accommodation for Statoil's workers
Allergy Therapeutics half yearly revenues grow amid market turmoil
Allergy Therapeutics said the global allergy treatment market had seen some “turmoil” that had affected the competitive market environment in Europe and the US.
Archive
Burberry Group shake-up well-received
Burberry’s surprise boardroom change yesterday gets plaudits from UBS
Archive
Proactive news highlights: FairFX, Allergy Therapeutics, SalvaRx, Akers Biosciences, GW Pharma & more
Low-cost currency provider FairFX enjoyed its best ever week last week thanks to heightened trading activity amid the UK’s EU referendum vote.
Allergy Therapeutics to take different approach to grass pollen jab
The next dose range study is planned to start next year with Allergy waiting until it hears the outcome of what’s called an End of Phase II meeting with the US Food & Drug Administration.
Allergy Therapeutics appoints ex- Skyepharma man as FD
Peter Jensen, Allergy’s chairman said Wykeham’s experience in life sciences was well suited to Allergy.
Proactive news highlights: Allergy Therapeutics, Bushveld, Metal Tiger, Windar and more...
Allergy Therapeutics' latest clinical study "encouraging", Metal Tiger makes new copper discovery in Thailand and Regency Mines to expand into oil and gas.
Imagination Technologies leads shares higher on bid talk
Chinese tech fund buys stake in graphics chip developer
Investments and investor services
Shares shrug off downbeat Chinese data
The Footsie rose 12 points to 6137 while small-cap indices also advanced
Allergy Therapeutics' results not to be sniffed at
The phase II trial assessed the response from 371 patients, which revealed a statistically significant dose-response relationship from the groups receiving the medication.
NetScientific PLC unveils Ian Postlethwaite as new CFO
We knew Postlethwaite was leaving Allergy Therapeutics after 14 years; now we know where he is going to
Archive
Proactive news summary: Allergy Therapeutics PLC, Eurasia Mining PLC, Metal Tiger PLC and more...
Sirius Minerals' "world class" North Yorkshire project, update on Aureus and Allergy Therapeutics to lose finance director.
Allergy Therapeutics PLC FD off to new pastures
“Ian leaves the company in the strongest position it has ever been in, in terms of sales, cash balance and growth potential...”
Investments and investor services
Admiral Group Plc boosted by big Nomura upgrade
Admiral Group Plc, RSA Insurance Group Plc, Barclays Plc, Meggit Plc, Genel Energy Plc and Fastjet Plc were all in Tuesday’s broker spotlight.
Investments and investor services
Westminster Group PLC provides a highlight on busy Tuesday for small caps
Westminster Group PLC, Forbidden Technologies PLC, KEFI Minerals PLC, Ten Alps, Sierra Rutile Ltd, RapidCloud International PLC, Allergy Therapeutics PLC, Regenersis PLC, Eckoh PLC, and Gulf Keystone Petroleum Limited were among Tuesday’s s
Allergy Therapeutics PLC outperforming the market
Not to be sneezed at: Allergy Therapeutics' ground-breaking allergy vaccines address several lucrative markets
Risers & fallers, including Westminster Group PLC, Kefi Minerals PLC and Ten Alps PLC
Kolar Gold and Zanaga don't know why their share prices are going up, meanwhile, for Tuesday's biggest AIM faller Messaging International it was all too clear ...
Allergy Therapeutics PLC grows in Europe and targets US
Revenue in the six months to December 31 rose 12% to £31.5mln
Forbidden Technologies plc set for Tuesday showcase
Forbidden’s final results will follow optimistic interims, released in September, which highlighted a re-focussing on sports and its consumer video editing platform eva.
Week Ahead: Argos owner could bow out on a low
Other big names reporting this week include the Pru, G4S and Paddy Power Betfair. Among small caps, updates from Telit, Forbidden Technologies and StatPro catch they eye
Archive
Brokers: Sirius Minerals, Rolls-Royce, Glencore, Allergy..
WH Ireland suggests the recent weakness in fertiliser group Sirius Minerals is an opportunity.
Archive
Proactive news highlights - Allergy Therapeutics, Mosman Oil & Gas, PureCircle and Stratex
Looking outside it might seem too early, but hay fever vaccine specialist Allergy Therapeutics is preparing for summer. .
Allergy Therapeutics enrols 250 for grass pollen allergy trial
The dose-setting trial for the vaccine, GrassMATAMPL, will involve 250 patients.
Archive
Proactive news summary: Ariana, Allergy Therapeutics, Epistem, Instem, IOG, Kibo, Metal Tiger ...
A round-up of the day's news from the small cap universe
Allergy Therapeutics posts double digit revenue growth
The company expects revenues to be in the order of £31.5mln in the first half of its financial year, which equates to a 12% rise at constant currencies.
e-Therapeutics hires life sciences veteran as chairman
Professor Malcolm Young is stepping down as chairman but will remain in his role as chief executive.
Archive
Brokers: ASOS to top the retail tree over Christmas
ASOS, Boo and SuperGroup to have full stockings, while M&S, Halfords and SPorts Direct may be disappointed says Peel Hunt
Allergy Therapeutics could gain from rival's problems, says Panmure
French group Stallergenes had to temporarily close its Antony manufacturing plant
Investments and investor services
Markets: Oil stocks push FTSE100 lower
The FTSE100 ended the day almost 15 points lower to 6,223.
Investments and investor services
Proactive news highlights: IOG, Motif Bio, allergy Therapeutics, ReNeuron, Immupharma and more
Sunrise Resources, Optibiotix Health and ITM Power also had news out
Markets: InternetQ hits back at online blog post
The FTSE100 was around 30 points higher at 6,267 with aerospace engine maker Rolls Royce leading the way.
Investments and investor services
Markets rise despite downbeat UK manufacturing news
The Footsie rose 30.9 points to 6269.19 while mainland European markets also gained
Allergy Therapeutics starts enrolment for US grass allergy trial
Up to half of the US suffers from inflammation and sneezing associated with seasonal allergic rhinitis/conjunctivitis
Investments and investor services
Proactive news highlights: Berkeley Energia, Acal, Clinigen, ZincOx, Sula Iron & Gold and more
Ferrex, Oilex and Allergy Therapeutics also had news out on Monday
Allergy Therapeutics ready to begin phase II trials on birch pollen innoculation
The point of the investigation is to find the optimal dose as well as assessing efficacy.
Investments and investor services
Proactive highlights - Allergy Therapeutics, Angle, Summit, VolitionRx, Faron Pharma, Camco Clean Energy, Mobile Streams & more
Here we take our daily look at the small cap news highlights of the trading day
Investments and investor services
Risers & Fallers: React Group, WS Atkins, Oilex, Carclo, Ferrex and Anglo American
Below are the main news-driven share price movements at 4pm.
Allergy Therapeutics raising £12mln for market step change
It said it will issue stock at 28p, using the proceeds to invest for new product development.
Archive
Proactive news summary: Allergy Therapeutics, Berkeley Energy, Forbidden Technologies, Gemfields ...
Pride of place goes to Plethora Solutions, after Jim Mellon's Regent Pacific offered to take it over.
Allergy Therapeutics to present data at World Vaccine Congress
It is an excellent opportunity to present this exciting data, says CSO Dr Murray Skinner
Allergy Therapeutics has major opportunity in US, says Stifel
Just for the grass vaccine allergy alone Stifel is predicting sales of US$400mln by 2023.
Investments and investor services
Proactive news highlights including Metminco, Versarien, Proxama, Landore, REM, DP Poland and more
A look at the big news from the world of small caps...
London stocks rise on Greek news and drug firm boost
Syriza emerged as the largest party in the latest Greek poll
Archive
Proactive news summary: African Potash, Falcon Oil, Allergy Therapeutics, Northcote, Rightster ...
It's deja vu all over again for African Potash as it inked another fertiliser deal.
Allergy Therapeutics recruits first patient to dosing trial
The company continues to make significant headway on a number of different fronts.
Investments and investor services
Proactive news highlights including Tethys, Rightster, Fastjet, Tern, Amur, Petropavlovsk and more
On a busy day in the world of small caps, Tethys Petroleum caught the eye...
Archive
Proactive news summary, including Atlantic Coal, Breedon Aggregates, ANGLE, cloudbuy, Madagascar Oil and Tethys Petroleum
Atlantic Coal shares advanced on Thursday as it saw anthracite sales rise strongly...
Investments and investor services
Risers & Fallers including Madagascar Oil, Allergy Therapeutics, Howden Joinery, Flybe and more
Atlantic Coal rose on improved sales while Daily Mail dropped after a decline in first quarter revenue.
Allergy Therapeutics' sales beat forecasts
Revenues on a constant currency basis are expected to be £46.6mln
Investments and investor services
Proactive news summary: Accesso, ATTRAQT, DiamondCorp, Europa, LGO, Providence, Strategic Mins ...
A number of technology companies were celebrating contract wins today.
ROUNDUP - Allergy Therapeutics shares rise as it reveals positive results from dust mite study
Allergy Therapeutics looks like it has another promising product for the corporate medicine chest.
Allergy Therapeutics to present dust mite data at key conference
Acarovac has been Allergy’s strongest growing treatment in Spain this year.
Archive
Greece saga pushes FTSE100 firmly lower
The full weight of the Greek saga made its presence felt on Footsie at the close....
Archive
Proactive news summary: Xtract Resources, Wolf Minerals, ValiRx, Trap Oil, Sula Iron & Gold ...
Lekoil was boosted by the chief executive topping up his holding but there was some grim news elsewhere from the oil sector.
Allergy Therapeutics’ momentum renewed with US programme kick-start
Allergy Therapeutics has renewed momentum - as its announcement this morning showing a kick-start to its US growth ambitions aptly demonstrated.
Allergy Therapeutics resumes development of allergy treatment in US
Allergy Therapeutics revealed it is returning to clinical development of Pollinex Quattro Grass - kick-starting the process of getting the firm's first product approved for the US market.
Investments and investor services
Proactive news summary - Ariana Resources, Alba Minerals, Falcon Oil & Gas, Premier African Minerals
Miners and oil stocks took to the stage today on a busy day for small caps.